急性缺血性卒中静脉溶栓中国卒中学会科学声明

被引:120
作者
机构
[1] 中国卒中学会科学声明专家组
关键词
卒中; 静脉; 溶栓; 时间窗; 特殊人群; 获益; 风险; 声明;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
1002 ;
摘要
1背景目前,急性缺血性卒中(acute ischemic stroke,AIS)最有效的药物治疗仍是超早期内(<4.5 h)给予重组组织型纤溶酶原激活剂(recombinant tissue plasminogen activator,rt-PA)静脉溶栓,因其可显著改善AIS预后,被国内外脑血管病指南一致推荐。2012年12月《中华内科杂志》发表的《重组组织型纤溶酶原激活剂静脉溶栓治疗缺血性卒中中国专家共识(2012版)》和2014年发表的《中国急性缺血性脑卒中诊治指南2014》对规范我国AIS
引用
收藏
页码:267 / 284
页数:18
相关论文
共 82 条
  • [1] 中国急性缺血性脑卒中早期血管内介入诊疗指南
    中华医学会神经病学分会
    中华医学会神经病学分会神经血管介入协作组
    急性缺血性脑卒中介入诊疗指南撰写组
    [J]. 中华神经科杂志, 2015, 48 (05) : 356 - 361
  • [2] 急性脑梗死六小时以内的静脉溶栓治疗
    国家“九五”攻关课题协作组
    [J]. 中华神经科杂志, 2002, (04) : 21 - 24
  • [3] Does Prior Antiplatelet Treatment Increase the Risk of Hemorrhagic Transformation and Unfavorable Outcome on Day 90 after Intravenous Thrombolysis in Acute Ischemic Stroke Patients[J] . Siyan Chen,Xia Lu,Wanli Zhang,Zhao Han,Wen Yang,Xuerong Huang,Xiaoping Jin,Zhiming Wang,Haiyan Liang,Weiwen Qiu,Jianhua Cheng,Bei Shao.Journal of Stroke and Cerebrovascular Diseases . 2016
  • [4] Case Report: A Novel Approach to the Treatment of Orolingual Angioedema After Tissue Plasminogen Activator Administration[J] . Lesley Pahs.Annals of Emergency Medicine . 2015
  • [5] Posterior vs. anterior circulation infarction: demography, outcomes, and frequency of hemorrhage after thrombolysis[J] . Tomá? Dorňák,Michal Král,Martin Hazlinger,Roman Herzig,Tomá? Veverka,Stanislav Bu?val,Daniel ?aňák,Jana Zapletalová,Kristyna Antalíková,Petr Kaňovsky.Int J Stroke . 2015 (8)
  • [6] IV thrombolysis in very severe and severe ischemic stroke: Results from the SITS-ISTR Registry[J] . Michael V. Mazya,Kennedy R. Lees,David Collas,Viiu-Marika Rand,Robert Mikulik,Danilo Toni,Nils Wahlgren,Niaz Ahmed.Neurology . 2015 (24)
  • [7] 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association[J] . William J. Powers,Colin P. Derdeyn,José Biller,Christopher S. Coffey,Brian L. Hoh,Edward C. Jauch,Karen C. Johnston,S. Claiborne Johnston,Alexander A. Khalessi,Chelsea S. Kidwell,James F. Meschi
  • [8] Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischemic stroke
    Wardlaw, Joanna M.
    von Kummer, Rudiger
    Carpenter, Trevor
    Parsons, Mark
    Lindley, Richard I.
    Cohen, Geoff
    Murray, Veronica
    Kobayashi, Adam
    Peeters, Andre
    Chappell, Francesca
    Sandercock, Peter A. G.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2015, 10 (06) : 956 - 968
  • [9] Future directions of acute ischaemic stroke therapy
    Fisher, Marc
    Saver, Jeffrey L.
    [J]. LANCET NEUROLOGY, 2015, 14 (07) : 758 - 767
  • [10] Safety and efficacy of desmoteplase given 3–9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial[J] . Gregory W Albers,Rüdiger von Kummer,Thomas Truelsen,Jens-Kristian S Jensen,Gabriela M Ravn,Bj?rn A Gr?nning,Hugues Chabriat,Ku-Chou Chang,Antonio E Davalos,Gary A Ford,James Grotta,Markku Kaste,Lee H Schwamm,Ashfaq Shuaib.The Lancet Neurology . 2015 (6)